HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sutimlimab, an investigational C1s inhibitor, effectively prevents exacerbation of hemolytic anemia in a patient with cold agglutinin disease undergoing major surgery.

AuthorsTor Henrik A Tvedt, Egil Steien, Bente Øvrebø, Rune Haaverstad, William Hobbs, Marek Wardęcki, Geir Erland Tjønnfjord, Sigbjørn Andreas Berentsen
JournalAmerican journal of hematology (Am J Hematol) Vol. 97 Issue 2 Pg. E51-E54 (02 01 2022) ISSN: 1096-8652 [Electronic] United States
PMID34778998 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal, Humanized
  • Complement Inactivating Agents
  • sutimlimab
Topics
  • Aged
  • Anemia, Hemolytic, Autoimmune (complications, prevention & control)
  • Antibodies, Monoclonal, Humanized (therapeutic use)
  • Cardiac Surgical Procedures
  • Complement Inactivating Agents (therapeutic use)
  • Coronary Disease (complications, surgery)
  • Humans
  • Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: